Positive Outlook on Novo Nordisk Maintained by BMO Capital Analyst
Evan Seigerman from BMO Capital maintains a Buy rating on Novo Nordisk (NVO) with a price [...]
Oral Adverse Events Following COVID-19 Vaccination: A Systematic Review
A recently published systematic review from Sood et al. investigated oral adverse events following COVID-19 vaccination, [...]
The Future of Telehealth: Policies, Equity, and Innovations
Telehealth usage surged during the COVID-19 pandemic, facilitating prompt care and overcoming logistical barriers. The Joint [...]
Prolacta’s Human Milk Diet Enhances Recovery for Gastroschisis Infants
Prolacta Bioscience announced data on the benefits of its Exclusive Human Milk Diet (EHMD) for term [...]
Global Cell-Free Protein Synthesis Market Projection
The global cell-free protein synthesis (CFPS) market is valued at $265.9 million in 2023, and is [...]
Wearable Health Monitoring Devices Revolutionize Clinical Trials
Wearable health monitoring devices have advanced rapidly, impacting clinical trials by enabling continuous, real-time data collection [...]
CRISPR Clinical Trial Shows Vision Improvements in Inherited Blindness
A Mass Eye and Ear-led Phase 1/2 trial, known as BRILLIANCE, tested a novel CRISPR-based therapy [...]
Algorithm-Based Remote Monitoring Cuts Mortality in Heart Failure Patients
Use of algorithm-based remote patient monitoring has substantially reduced all-cause mortality in heart failure (HF) patients [...]
U.S. Clinical Trial Imaging Market Growth Forecast
The U.S. clinical trial imaging market, valued at USD 409.50 million in 2023, is projected to [...]
The Digital Transformation Dilemma for Life Science Research
Unsurprisingly, data is the foundation of drug and therapy development, with modern technologies accelerating data collection [...]
The Importance of Cost-Effectiveness in Public Health Policy
Evaluating the cost-effectiveness of interventions is crucial to optimize resource allocation and impact across public health [...]
Real-World Evidence on Rituximab Efficacy for Multiple Sclerosis
Rituximab is an anti-CD20 monoclonal antibody, and in addition to treating cancers and autoimmune conditions like [...]
Exercise-Induced Hypertension Increases Risk of Sudden Cardiac Death
A recent review in the Journal of Clinical Medicine highlights exercise-induced hypertension (EIH) as a risk [...]
Two Case Studies Navigating AI Patent Claims in Healthcare and MedTech
Artificial intelligence (AI) has been transforming healthcare and medical technologies, but it introduces complex legal challenges [...]
AstraZeneca Begins Global Withdrawal of COVID-19 Vaccine
AstraZeneca has initiated a global withdrawal of its COVID-19 vaccine as demand has declined. Initially celebrated [...]
Medicare Hospital Insurance Trust Fund Gains Extended Solvency Amid Challenges
This year's annual Medicare Trustee report states that the Hospital Insurance Trust Fund (HI Trust Fund) [...]
WuXi Biologics Withdraws from BIO Convention Amid U.S. Tensions
Production specialist WuXi Biologics has opted out of the 2024 BIO International Convention following U.S. biosecurity [...]
Thermo Fisher’s $912.5 Million Acquisition Expands Clinical Research with CorEvitas Purchase
Thermo Fisher Scientific has acquired CorEvitas for $912.5 million from Audax Private Equityin to enhance its [...]
Effectiveness of Semaglutide in Real-World Weight Management
While recent studies confirm semaglutide's efficacy in significant weight reduction among overweight and obese adults, limited [...]
Insights into Treatment Resistant Depression in Portugal
The disease burden from treatment resistant depression (TRD) in Portugal has surpassed that of heart failure. [...]
Medline Acquires Ecolab’s Surgical Solutions Division in $950 Million Deal
Medline is set to acquire Ecolab's surgical solutions division for nearly $1 billion, increasing their presence [...]
AstraZeneca’s Advance into Respiratory Health at ATS 2024
AstraZeneca plans to highlight their comprehensive respiratory portfolio at the American Thoracic Society (ATS) International Conference [...]
Enhanced Efficacy of a Cell-Based Influenza Vaccine
The superior effectiveness of the cell-based quadrivalent influenza vaccine (QIVc) compared to the traditional egg-based vaccine [...]
Strategic Shifts for BioMarin’s Gene Therapy Roctavian Amid Market Challenges
BioMarin's gene therapy for hemophilia A, Roctavian, received approval in Europe in 2022 and the U.S. [...]
RWE Solutions Market Predicted to Reach $78.83 Billion by 2030
The global Real World Evidence (RWE) Solutions Market is projected to grow substantially, from USD 43.22 [...]